Connect with us

CBD

10 of the best CBD oils for diabetes

Published

on

Cannabidiol (CBD) is a natural compound that comes from the cannabis sativa plant. It can help treat diabetes. However, there can be risks associated with using CBD products, and CBD may not be suitable for those with certain health conditions, or for those who are pregnant or breastfeeding.

There is currently no cure for diabetes, but a person can control the condition with diabetes drugs such as insulin, alpha-glucosidase inhibitors, and biguanides.

Some research has looked at whether or not CBD oil may also help with diabetes, although it is currently not a regulated treatment for the condition.

This article examines whether CBD can help with diabetes, some safety issues, and some products to consider.

Is CBD Legal? Hemp-derived CBD products with less than 0.3% THC are legal nationwide, but are still illegal under some state laws. On the other hand, cannabis-derived CBD products are illegal nationwide, but legal under some state laws. Check local laws, especially when traveling. Also note that the Food and Drug Administration (FDA) has not approved any nonprescription CBD products that may be inaccurately labeled.

Cannabis sativa, the plant that people can call marijuana or hemp, contains two active ingredients: delta-9-tetrahydrocannabinol (THC) and CBD.

THC contains psychoactive properties, so it can cause euphoria.

CBD, on the other hand, is not euphoric, although it may contain small traces of THC. People who use CBD will not feel the high sensation associated with cannabis use.

Learn more about CBD and THC here.

Types of CBD

There are three types of CBD products. These are:

  • Full spectrum CBD: This type of CBD contains naturally occurring extracts from the cannabis plant and up to 0.3% THC.
  • Broad spectrum CBD:: This type of CBD is made from naturally occurring compounds from the cannabis plant and does not contain traces of THC.
  • CBD isolate: This is the pure form of CBD, which means it is free from THC, plant compounds, and cannabinoids. It is odorless and has no taste.

Learn more about the differences between full and broadband CBD here.

Diabetes is a chronic condition that affects a person’s blood sugar or sugar regulation.

Glucose comes from the food people eat, which the body then releases into the bloodstream. When a person’s blood sugar levels rise, the pancreas releases insulin and helps glucose get into their body’s cells for energy.

The Centers for Disease Control and Prevention (CDC) state that a person can develop diabetes if a person’s body does not make enough insulin or if their cells do not respond to insulin. As a result, a person with diabetes may have too much sugar in their blood.

According to the American Diabetes Association (ADA), high blood sugar levels can increase your risk for other health conditions, including:

Types of Diabetes

There are three types of diabetes. These are:

  • Type 1 diabetes:: Type 1 diabetes occurs when the body does not make insulin and people are usually diagnosed with this type in childhood. The CDC states that 5-10% of people with diabetes have type 1 diabetes.
  • Type 2 diabetes:: Type 2 diabetes occurs when the body doesn’t make or use insulin well. According to the CDC, 90-95% of people with diabetes have type 2 diabetes.
  • Gestational diabetes: This type of diabetes can develop during pregnancy but usually goes away after the person is born.

The ADA claims the Food and Drug Administration (FDA) does not regulate CBD products for diabetes.

According to the Arthritis Foundation, people with arthritis are more likely to develop diabetes than people with healthy blood sugar levels. A 2017 study looked at the effects of CBD in rats with osteoarthritis. CBD was found to reduce both inflammation and pain related to the condition.

In another 2019 study, researchers found that 30-day CBD treatment improved memory performance and decreased nerve inflammation in rats with chronic cerebral hypoperfusion and diabetes.

Additionally, in a 2015 study, researchers found that CBD reduced inflammation and neurotoxicity in rats with diabetes. As a result, the researchers concluded that products containing CBD can be beneficial for people with diabetic retinopathy.

Possible side effects of CBD

A 2017 review states that CBD can cause:

  • fatigue
  • nausea
  • Changes in appetite
  • Weight changes

The following sections highlight 10 of the best CBD products for diabetes.

Please note that the author of this article has not tried any of these products. All information presented here is purely research-based.

CBDfx CBD + CBG oil wellness tincture

This vegan, gluten-free product is available in a variety of strengths ranging from 500 to 6,000 milligrams (mg) of broad spectrum CBD.

It contains cannabigerol (CBG), a non-euphoric ingredient that comes from the cannabis plant. It also contains curcumin and coenzyme Q10.

A 2017 review stated that curcumin had antioxidant and anti-inflammatory properties. It can help a person maintain a moderate weight and improve memory performance.

Coenzyme Q10 is also an antioxidant and is used as an energy supplement.

The manufacturer suggests that people take the dropper, place the drops under their tongue, and hold them there for 20 to 60 seconds. It says that a person can use this tincture on a daily basis.

Sabaidee Super Good Vibes CBD Oil

This product contains 1,000 mg of broad spectrum CBD oil. The pipette contains over 33.5 mg of CBD.

The manufacturer uses CO2 extraction technology to eliminate unwanted amounts of THC and other elements.

Sabaidee suggests that people use the oil one to three times a day. However, if this is not effective, a person may want to increase the dose two to three times.

NuLeaf Naturals CBD Oil

The NuLeaf Naturals CBD oil product consists of 60 mg of full-spectrum CBD per milliliter (ml) and the portion sizes are between 300 and 6,000 mg.

It contains cannabinoids, terpenes, essential oils, and other phytonutrients. The manufacturer uses its CO2 extraction technology to ensure that no heat or solvents affect the quality of the products.

NuLeaf claims that its products are free of pesticides, heavy metals and mycotoxins.

RoyalCBD CBD oil

RoyalCBD’s CBD oil is a 1,000 mg full spectrum product that contains 33 mg of CBD per ml. It contains terpene and hemp oil extract that contains vitamin E.

A recent study found that high-dose vitamin A combined with vitamin E supplements and zinc can improve insulin secretion in people with type 2 diabetes.

The manufacturer recommends that people press a few drops under their tongue and swallow them after 1–2 minutes.

Gold Bee CBD Oil

Gold Bee tincture is a full-spectrum CBD oil that consists of 10–40 mg of CBD per ml. The manufacturer claims that it is suitable for vegans and does not use genetically modified organisms (GMOs).

The product is available in concentrations of 1,200 and 2,400 mg.

It is available in kiwi and natural flavors and contains CBD, MCT oil, and terpenes. Honey and stevia extracts are also part of the natural taste.

One study looked at the benefits of combining honey and prescription drugs in rats with diabetes. It was found that these boosted antioxidant defenses and reduced oxidative kidney damage.

The manufacturers suggest that people put a drop of CBD oil under their tongue and swallow it after 60 seconds. Gold Bee also suggests that people can use their tongues to move the oil around their mouths to absorb the CBD oil into the bloodstream.

Medterra CBD oil

This CBD isolate product consists of 16, 33 and 100 mg of CBD per ml and its strengths are between 500 and 3,000 mg.

Medterra claims its products are free from:

The manufacturer also claims that it is part of the United States Hemp Authority Program. Medterra also states that its CBD products comply with the Kentucky Department of Agriculture’s hemp licensing program.

Populum full spectrum hemp CBD oil

This product comes in a 300 ml bottle and has a strength of 250 to 2,000 mg.

The manufacturer claims that its products are:

Manufacturers recommend starting with a dose of 8 mg to 8.5 mg per day. You can adjust the dose as you wish, but Populum suggests that a person stick to the same CBD routine for 30 days.

cbdMD CBD oil tincture

The cbdMD product comes in two forms: 30 ml drops with strengths between 300 and 7,500 mg and 60 ml drops with strengths between 1,000 and 1,500 mg.

cbdMD claims that its products are:

  • vegan
  • gluten free
  • Good Manufacturing Practice certified
  • THC free

The manufacturer also states that the oil can help with:

  • support a sense of calm
  • Promote recovery from exercises
  • Enable better stress management

The manufacturer says that pregnant or breastfeeding people should seek medical advice before using this product and cautions that it may cause drowsiness.

Lazarus Naturals Classic highly effective CBD tincture

This tincture is a full spectrum CBD oil that consists of 50 mg of CBD per ml.

It comes in 15, 60, and 120 ml bottles, and serving sizes range from 750 to 6,000 mg.

The manufacturers suggest that people start on 50 mg to find the right amount for them. After 2 hours you can increase the dose as needed.

It also warns that people who have received advice not to eat grapefruit should see a doctor before using this product.

Joy Organics CBD tincture

This tincture contains 30 servings and is available in strengths between 450 and 1,350 mg.

Joy Organics claims this product is:

  • tested in the laboratory
  • THC free
  • cruelty free

The manufacturer also states that this tincture:

CBD

Kansas farmers struggling to sell hemp for industrial purposes

Published

on

PRATT – This summer marks the third year Kansans has been growing hemp for industrial purposes.

However, growing the plant’s less sexy cousin, associated with climbing high and some medicinal uses, has proven riskier and more difficult than many farmers originally anticipated.

As a result, the number of licenses issued this year is less than half of what the state saw in 2020.

“There has been some misunderstanding about ease of marketability,” said Braden Hoch, the state director of the industrial hemp program.

More:Will hemp be a boon for farmers? Kansas reports say it’s too early to tell

A farm’s risk is exacerbated by an ever-changing set of state and federal regulations. And now some hemp growers and processors want more help from the government to reduce risk and encourage innovation.

Shining Star Hemp Co. is one of only 11 licensed hemp processors in the state.

Outside the industrial building near Pratt Municipal Airport in south-central Kansas where Shining Star operates are rows of 1,200-pound sacks of industrial hemp stems, grains and flowers.

Inside, workers break open the sacks and toss them onto a large conveyor belt that leads to a cacophony of machines that shake, blow, and sift the biomass into its usable parts.

The company is one of the few successful companies in the state.

“It was a lot of work, lots of phone calls to build relationships and find synergies,” said Jennifer Holmes, who works with Shining Star to develop and market products. “But to be honest, I can say at this point that we are great for our position.”

Complex process that is holding back the hemp industry

Paul McGeary developed Shining Star’s system for converting the hemp crop into something that the industry can use.

“It’s probably about 30 years of banging your head against the wall, mostly,” he said.

McGeary is a contractor for Shining Star. He has worked in the agricultural processing world for most of his life and applied what he learned over decades of sieving wheat and corn to develop this machine for sieving hemp.

He said the complexity of the process is part of what is holding the industry back. It just isn’t the size to cater to manufacturers who would use the fiber.

“We went to these meetings thinking that having £ 30,000 to £ 40,000 on hand was something. But when you get into the industry and they want five wagons a day or a trainload a week, we’re just not prepared for that, ”he said. “And making them wait until we are prepared is the bottleneck of the whole thing.”

More:The demand for hemp fiber is growing as manufacturers consider an untapped market

Hemp has been hyped as something with a wide variety of industrial uses. The stem can be made from paper or biodegradable plastics. The seeds can be processed into food. And the flowers can be pressed to extract oils.

But so far the only market the industry is pushing seems to be for their cannabinoid-rich or CBD oil. And there is already a deluge of CBD on the market.

“We’re not very lucky to sell full-spectrum oil,” said Holmes. “It’s just something that we all have to work through and do the right thing and get into the grain and fiber industry.”

But that’s going to cost millions of dollars in investments in new equipment.

Until this equipment can be designed, built, or purchased, companies interested in making products from hemp fiber are out of luck. A company in Newton wants to make limbs out of hemp. It imports its processed hemp from overseas.

The licenses for hemp cultivation will decrease in 2021

Holmes wants more government aid to offset some of the risk of investing in converting the facility into something useful for industry.

“A lot of people are scared to start because they don’t know if they’re going to fail, so they never start,” she said.

The Kansas Department of Agriculture says its hemp growing licenses have dropped from 218 in 2020 to just 81 this year.

And last year, of the nearly 4,000 hectares that were planted, only 761 were harvested for production.

An eighth of it had to be burned by the state because it contained too much of the psychoactive chemical THC.

“The last two years have really helped individuals stay up to date,” said Hoch. “But producers still determine how hemp can best be grown as a useful crop and incorporated into their crop rotation.”

He said growers and processors need to expand beyond CBD products, but as federal and state regulations for harvesting are constantly changing, finding the right investors to embrace this kind of innovation and development will remain difficult can drive forward.

Brian Grimmett reports on the environment, energy and natural resources for SMBs in Wichita and the Kansas News Service.

Continue Reading

CBD

Europe CBD Oil Market Report 2021-2026

Published

on

According to the latest IMARC Group report entitled “European CBD Oil Market: Industry trends, share, size, growth, opportunities and forecast 2021-2026,“The European CBD oil market will grow at a CAGR of around 23% over the period 2021-2026.

Cannabidiol (CBD) is a non-psychoactive compound made from resins, leaves, and flowers of the marijuana or hemp plant. To make CBD oil, cannabidiol is extracted from the cannabis plant and diluted with a carrier oil such as coconut oil. CBD oil is high in amino acids, iron, fiber, zinc, etc. In addition to having a relieving effect on depression, anxiety, insomnia, seizures, etc., the oil is also used to relieve pain, improve heart health, relieve cancer . related symptoms, acne treatment, etc.

Like the novel Coronavirus (COVID-19) When the crisis has conquered the world, we continuously monitor changes in the markets and the behavior of consumers in the industry worldwide, and our estimates of the latest market trends and forecasts are made taking into account the effects of this pandemic.

CBD Oil Market Trends in Europe:

The increasing legalization of cannabidiol in several European countries is primarily driving the market for CBD oil. In addition, the increasing prevalence of various neurological and psychiatric disorders is also catalyzing product demand for treating such disorders. Accordingly, CBD oil infused supplements are increasingly being used in cancer treatment to minimize the side effects of chemotherapy such as weight loss, nausea, fatigue, etc. In addition, the advancing pharmaceutical industry and the increasing use of bioactive ingredients in medicines will continue to support product demand. In addition, the increasing use of CBD oil in cosmetics and personal care products is expected to further strengthen the European CBD oil market in the coming years due to its anti-inflammatory and anti-aging properties.

Request a free sample report: https://www.imarcgroup.com/europe-cbd-oil-market/requestsample

European CBD Oil Market 2021-2026 Analysis and Segmentation:

Competitive landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the major players operating in the market.

Aurora Cannabis, Diamond CBD Inc., ENDOCA, APHRIA Inc., ConnOils LLC, Elixinol Global Limited, Emblem CANNABIS, NuLeaf Naturals, LLC, CBD Ultra Limited and The Original Alternative Limited.

The report has segmented the market by region, disc type, material type and end-user.

Distribution according to source:

  • Marijuana based
  • Based on hemp

breakup from Product Type:

breakup from Product category:

breakup from application:

  • food and drinks
  • personal hygiene
  • Health care
  • Nutraceuticals
  • Other

breakup from Distribution channel:

Distribution by country:

  • Germany
  • Spain
  • Italy
  • France
  • United Kingdom
  • Russia
  • Rest of Europe

Ask the analyst about customization and explore the full report with table of contents and list of figures: https://www.imarcgroup.com/europe-cbd-oil-market

Main highlights of the report:

  • Market performance (2015-2020)
  • Market Outlook (2021-2026)
  • Porter’s Five Forces Analysis
  • Market drivers and success factors
  • SWOT analysis
  • Value chain
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently included in the scope of the report, we can provide it to you as part of the customization.

When you need the latest primary and secondary data (2021-2026) with cost module, business strategy, sales channel, etc. Click Request Free Sample Report, the published report will be emailed to you in PDF format within 24-48 hours of receipt in full payment.

about us

The IMARC Group is a leading market research company offering management strategy and market research worldwide. We work with clients in all sectors and regions to identify their most valuable opportunities, address their key challenges, and transform their businesses.

IMARC’s information products encompass key market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high technology companies. Market forecasts and industry analyzes for biotechnology, advanced materials, pharmaceuticals, food & beverage, travel & tourism, nanotechnology and innovative processing methods are at the forefront of the company’s expertise.

Contact us:

IMARC group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Telephone: (D) +91 120 433 0800
America: – +1 631 791 1145 | Africa and Europe: – + 44-702-409-7331 | Asia: + 91-120-433-0800, + 91-120-433-0800

Continue Reading

CBD

CBDistillery™ Sets Aside Thousands Of Products To Advance The Efficacy of Hemp-Derived Wellness Products

Published

on

DENVER, June 17, 2021 / PRNewswire / – CBDistillery ™, one of the country’s leading CBD brands, is partnering with Releaf App ™, the top-rated application for individuals to track, learn from, and improve their use of cannabis and CBD Learn more about customers’ reported on the use and effectiveness of CBDstillery ™ products. CBDistillery ™ aims to be the leading educational resource and “one-stop shop” for consumers interested in hemp-derived CBD, CBG and CBN products. To provide educational resources and personalized data insights to their customers, CBDistillery ™, in partnership with Releaf App ™, is giving away thousands of free CBD products to people who sign up for private studies called Pathfinder Missions ™.

CBDistillery ™ plans to announce up to eight unique Pathfinder Missions ™ in 2021 using Releaf App ™ technologies, which are mobile and web-based applications used by brands to collect data on the usage and performance of Collect cannabis and CBD products. The first CBDistillery ™ PathFinder Mission ™ is available to eligible participants on. ready to register March 23. Participants will answer a series of questions twice a week for 60 consecutive days to measure their dosage and overall experience with CBDistillery ™ products.

Eligible participants will receive two free CBDistillery ™ products – a 1000 mg CBD isolate oil and a 1000 mg broad-spectrum CBD oil. During the first 30 days of the PathFinder Mission ™, individuals will answer questions about their use and experience with the isolate-based product. They will then switch the product they use and answer questions from the past 30 days about their use and experience with the Broad Spectrum product. All individuals who complete the PathFinder Mission ™ will receive an exclusive offer from CBDistillery ™.

CBDistillery ™ and Releaf App ™ are currently enrolling individuals upon first arrival, up to 500 eligible participants. Click here or visit releaf.at/cbdistillerystress to learn more, sign up, and determine your eligibility.

“At Balanced Health Botanicals, we invest in improving the effectiveness of hemp-derived wellness products through dynamic, research-based partnerships. In doing so, we empower and equip consumers with validated and objective data on CBD, CBG and CBN products that will help “The brand wins trust and loyalty in a very competitive industry,” says Tony Schwartz, Director of Associated and Strategic Partnerships. “We are excited to be working with the Releaf App team as it has uniquely established itself as a lean research service provider with exceptional customer service. The opportunity to work with Releaf App as a technology and data provider to identify groundbreaking insights is exciting for everyone at the table. “

“CBD brands often struggle to gather real-time, data-driven product insights from their customers. We are excited to help Balanced Health Botanicals collect meaningful data to fulfill their commitment to advancing customer education and improving product innovation. ”Says Keenan Keeling, CEO of MoreBetter Ltd, the company behind the Releaf App.

About CBD Distillery ™
CBDistillery ™ was founded in 2016 with the belief that everyone deserves access to high quality, effective and affordable CBD products. As part of this vision, the brand has over 2 million people in The United States and continues to invest in products with the aim of helping people regain control of their health and wellbeing.

Via the Releaf app
MoreBetter (dba Releaf App) is a software-as-a-service provider and contract research organization that provides data insights and is powered by patent-pending technology that gathers real-world evidence-based results from cannabis and hemp users to businesses , Medical professionals, researchers, government organizations and related stakeholders in the cannabis supply chain. MoreBetter uses the information gathered in the Releaf app to provide data-driven insights into seed-to-outcome trends that inform industry best practices and improve the consumer experience.

SOURCE Balanced Health Botanicals

Continue Reading
Advertisement

Trending